{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:41:22Z","timestamp":1768704082578,"version":"3.49.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00021","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T05:37:20Z","timestamp":1580276240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets"],"prefix":"10.3389","volume":"11","author":[{"given":"Denis","family":"Ciato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Albani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing's syndrome","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1210\/jc.2018-02080","article-title":"Tumor-directed therapeutic targets in cushing disease","volume":"104","author":"Theodoropoulou","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13543784.2017.1266338","article-title":"Currently used and investigational drugs for Cushing s disease","volume":"26","author":"Ciato","year":"2017","journal-title":"Expert Opin Investig Drugs."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1210\/jcem-71-6-1427","article-title":"Clonal origin of pituitary adenomas","volume":"71","author":"Herman","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1210\/jcem.75.5.1358909","article-title":"Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease","volume":"75","author":"Biller","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1210\/jcem.75.2.1322426","article-title":"Monoclonality of corticotroph macroadenomas in Cushing's disease","volume":"75","author":"Gicquel","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cen.13457","article-title":"Genetics of Cushing's disease","volume":"88","author":"Albani","year":"2018","journal-title":"Clin Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1210\/jcem-20-12-1539","article-title":"Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome","volume":"20","author":"Liddle","year":"1960","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0303-7207(02)00280-0","article-title":"Glucocorticoid receptors and Cushing's disease","volume":"197","author":"Lamberts","year":"2002","journal-title":"Mol Cell Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"T99","DOI":"10.1530\/JME-15-0289","article-title":"60 YEARS OF POMC: transcriptional and epigenetic regulation of POMC gene expression","volume":"56","author":"Drouin","year":"2016","journal-title":"J Mol Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/archinte.1965.03870020012006","article-title":"Diagnosis of Cushing's syndrome: single dose dexamethasone suppression test","volume":"116","author":"Nungent","year":"1965","journal-title":"Arch Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1126\/science.1325670","article-title":"The cloning of a family of genes that encode the melanocortin receptors","volume":"257","author":"Mountjoy","year":"1992","journal-title":"Science."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/edrv-5-1-1","article-title":"Corticosteroid inhibition of ACTH secretion","volume":"5","author":"Keller-Wood","year":"1984","journal-title":"Endocr Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0022-4731(89)90066-6","article-title":"Glucocorticoid repression of pro-opiomelanocortin gene transcription","volume":"34","author":"Drouin","year":"1989","journal-title":"J Steroid Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4158\/EP11061.RA","article-title":"The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors","volume":"17","author":"Briassoulis","year":"2011","journal-title":"Endocr Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"E6466","DOI":"10.1073\/pnas.1703779114","article-title":"Dynamic responses of the adrenal steroidogenic regulatory network","volume":"114","author":"Spiga","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nsmb.2456","article-title":"The structural basis of direct glucocorticoid-mediated transrepression","volume":"20","author":"Hudson","year":"2013","journal-title":"Nat Struct Mol Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0303-7207(85)90154-6","article-title":"Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH","volume":"40","author":"Gagner","year":"1985","journal-title":"Mol Cell Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/mend.11.1.9874","article-title":"Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1\/nur77 subfamily of nuclear receptors","volume":"11","author":"Murphy","year":"1997","journal-title":"Mol Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1128\/MCB.17.10.5952","article-title":"Antagonism between Nur77 and glucocorticoid receptor for control of transcription","volume":"17","author":"Philips","year":"1997","journal-title":"Mol Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1101\/gad.1444606","article-title":"Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease","volume":"20","author":"Bilodeau","year":"2006","journal-title":"Genes Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1210\/jcem-67-2-279","article-title":"Characterization of corticotropin-releasing hormone receptors on human pituitary corticotroph adenomas and their correlation with endogenous glucocorticoids","volume":"67","author":"Grino","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1172\/JCI113557","article-title":"Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro","volume":"82","author":"Suda","year":"1988","journal-title":"J Clin Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/edrv-17-3-245","article-title":"Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids","volume":"17","author":"Bamberger","year":"1996","journal-title":"Endocr Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mce.2008.10.001","article-title":"Molecular mechanisms regulating glucocorticoid sensitivity and resistance","volume":"300","author":"Gross","year":"2009","journal-title":"Mol Cell Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease","volume":"9","author":"Quax","year":"2013","journal-title":"Nat Rev Endocrinol."},{"key":"B36","first-page":"296","article-title":"Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation","volume":"108","author":"Karl","year":"1996","journal-title":"Proc Assoc Am Physicians."},{"key":"B37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1365-2265.2002.01639.x","article-title":"Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours","volume":"57","author":"Antonini","year":"2002","journal-title":"Clin Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1210\/jc.82.4.1088","article-title":"Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors","volume":"82","author":"Dahia","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1530\/EJE-07-0428","article-title":"Differential gene expression in ACTH -secreting and non-functioning pituitary tumors","volume":"157","author":"Tateno","year":"2007","journal-title":"Eur J Endocrinol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2265.2010.03805.x","article-title":"HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas","volume":"73","author":"Evang","year":"2010","journal-title":"Clin Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1210\/me.2010-0091","article-title":"Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis","volume":"24","author":"Roussel-Gervais","year":"2010","journal-title":"Mol Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1210\/jcem.86.6.7563","article-title":"Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors","volume":"86","author":"Korbonits","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"18473","DOI":"10.1074\/jbc.R800007200","article-title":"The Hsp90 chaperone machinery","volume":"283","author":"Wandinger","year":"2008","journal-title":"J Biol Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/348166a0","article-title":"Reduced levels of hsp90 compromise steroid receptor action in vivo","volume":"348","author":"Picard","year":"1990","journal-title":"Nature."},{"key":"B47","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat Rev Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nm.3776","article-title":"A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease","volume":"21","author":"Riebold","year":"2015","journal-title":"Nat Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat Rev Cancer."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of silymarin in the treatment of liver diseases","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs."},{"key":"B51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejmech.2015.12.041","article-title":"Silibinin derivatives as anti-prostate cancer agents: synthesis and cell-based evaluations","volume":"109","author":"Vue","year":"2016","journal-title":"Eur J Med Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"EJE-19","DOI":"10.1530\/EJE-19-0677","article-title":"Geoffrey Harris Award 2019: translational research in pituitary tumors","volume":"182","author":"Stalla","year":"2019","journal-title":"Eur J Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1210\/me.2013-1422","article-title":"Minireview: pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4","volume":"28","author":"Lin","year":"2014","journal-title":"Mol Endocrinol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1073\/pnas.1306182110","article-title":"Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease","volume":"110","author":"Du","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1210\/jc.2016-1379","article-title":"Testicular receptor-4: novel regulator of glucocorticoid resistance","volume":"101","author":"Zhang","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"69149","DOI":"10.18632\/oncotarget.12381","article-title":"Targeting the ERK pathway for the treatment of Cushing's disease","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00021\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T05:37:22Z","timestamp":1580276242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00021\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":56,"alternative-id":["10.3389\/fendo.2020.00021"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00021","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"article-number":"21"}}